Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”) and Bispecific ADCs (“BsADCs), announced that it has been selected to participate in Seed ...

JPMorgan Chase & Co. (NYSE: JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm ...

In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, ...

AdventHealth and Novant Health have set $30 billion annual revenue targets, fueled by a growing demand for care and interest ...

Alignment Healthcare is looking a bit lonely at the J.P. Morgan Healthcare Conference. CEO John Kao doesn’t really mind.

For over a decade, I’ve kicked off the year with the J.P. Morgan Healthcare Conference—an exciting moment to connect with ...

Unfortunately for the company, however, the early glimpse at its fourth-quarter performance doesn’t seem to be going over ...

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

The fixed-income trading business posted $2.74 billion in revenue, driven by gains in currencies, mortgages and credit ...